Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Inventory: 2018-2024

Historic Inventory for Agios Pharmaceuticals (AGIO) over the last 6 years, with Dec 2024 value amounting to $27.6 million.

  • Agios Pharmaceuticals' Inventory rose 21.21% to $32.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.0 million, marking a year-over-year increase of 21.21%. This contributed to the annual value of $27.6 million for FY2024, which is 44.77% up from last year.
  • Latest data reveals that Agios Pharmaceuticals reported Inventory of $27.6 million as of FY2024, which was up 44.77% from $19.1 million recorded in FY2023.
  • Over the past 5 years, Agios Pharmaceuticals' Inventory peaked at $27.6 million during FY2024, and registered a low of $8.5 million during FY2022.
  • Its 3-year average for Inventory is $18.4 million, with a median of $19.1 million in 2023.
  • Data for Agios Pharmaceuticals' Inventory shows a peak YoY spiked of 124.63% (in 2023) over the last 5 years.
  • Yearly analysis of 4 years shows Agios Pharmaceuticals' Inventory stood at $14.7 million in 2020, then reached $8.5 million in 2022, then soared by 124.63% to $19.1 million in 2023, then soared by 44.77% to $27.6 million in 2024.